文献速递慢性肾脏病急性肾损伤

肾功能多基因风险评分与循环蛋白质组及新发肾脏疾病的关联

Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases.
PubMed 文献 · J Am Soc Nephrol · 2021-12-01

研究基于CKDGen和UK Biobank数据构建eGFR多基因风险评分(PRS),在ARIC队列中验证其与CKD、ESKD、肾衰竭和AKI的关联,并分析PRS与4877种血浆蛋白的关系。结果显示PRS与所有结局显著相关,每降低1个标准差的风险比范围为1.06至1.33,且PRS与132种蛋白显著相关,多数关联由eGFR介导。

要点

  • eGFR的PRS与CKD、ESKD、肾衰竭和AKI风险均显著相关。
  • PRS与132种血浆蛋白显著相关,最强为胱抑素C、胶原α-1(XV)链和桥粒胶蛋白-2。
  • 多数PRS-蛋白关联由eGFR介导,提示PRS主要通过影响肾功能发挥作用。

核心结论

  • eGFR的多基因风险评分能有效捕捉一系列新发肾脏疾病的风险,并广泛影响血浆蛋白质组,且主要经eGFR介导。

研究设计与样本

  • 利用CKDGen多民族荟萃分析(n=765,348)和UK Biobank GWAS(90%队列,n=451,508)的汇总数据,通过LDpred算法构建eGFR PRS,并在UK Biobank剩余10%(n=45,158)中选择最佳参数。
  • 在ARIC研究(n=8866)中验证PRS与新发CKD、ESKD、肾衰竭和AKI的关联,并检测PRS与中年及老年期4877种血浆蛋白的关联。

主要发现

  • PRS与所有结局显著相关,每降低1个标准差的风险比范围为1.06(95% CI, 1.01-1.11)至1.33(95% CI, 1.28-1.37)。
  • PRS与132种蛋白在两个时间点均显著相关,最强关联为胱抑素C、胶原α-1(XV)链和桥粒胶蛋白-2。
  • 多数蛋白在肾功能较低时升高,但包括testican-2在内的5种蛋白例外;PRS与蛋白的大多数相关性由eGFR介导。

临床怎么用

  • PRS可作为识别肾脏疾病高风险个体的工具,但需进一步验证其临床效用。
  • PRS对血浆蛋白质组的影响主要通过eGFR介导,提示监测eGFR变化可能部分反映遗传风险。

局限性

  • 研究结果基于特定人群(ARIC),普适性需在其他人群中验证。
  • PRS构建主要依赖欧洲人群数据,可能限制跨种族应用。
  • 仅评估了关联,未确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genome-wide association studies (GWAS) have revealed numerous loci for kidney function (eGFR). The relationship between polygenic predictors of eGFR, risk of incident adverse kidney outcomes, and the plasma proteome is not known. METHODS: We developed a genome-wide polygenic risk score (PRS) for eGFR by applying the LDpred algorithm to summary statistics generated from a multiethnic meta-analysis of CKDGen Consortium GWAS ( n =765,348) and UK Biobank GWAS (90% of the cohort; n =451,508), followed by best-parameter selection using the remaining 10% of UK Biobank data ( n =45,158). We then tested the association of the PRS in the Atherosclerosis Risk in Communities (ARIC) study ( n =8866) with incident CKD, ESKD, kidney failure, and AKI. We also examined associations between the PRS and 4877 plasma proteins measured at middle age and older adulthood and evaluated mediation of PRS associations by eGFR. RESULTS: The developed PRS showed a significant association with all outcomes. Hazard ratios per 1 SD lower PRS ranged from 1.06 (95% CI, 1.01 to 1.11) to 1.33 (95% CI, 1.28 to 1.37). The PRS was significantly associated with 132 proteins at both time points. The strongest associations were with cystatin C, collagen α -1(XV) chain, and desmocollin-2. Most proteins were higher at lower kidney function, except for five proteins, including testican-2. Most correlations of the genetic PRS with proteins were mediated by eGFR. CONCLUSIONS: A PRS for eGFR is now sufficiently strong to capture risk for a spectrum of incident kidney diseases and broadly influences the plasma proteome, primarily mediated by eGFR.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Yu Z, Jin J, Tin A, et al. Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases. J Am Soc Nephrol. 2021. PMID: 34548389. doi:10.1681/ASN.2020111599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。